http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-343405-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_22b9baa71ceef111b94d9fcf4391f1f0
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-1045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-1093
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-1051
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0478
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-1072
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04
filingDate 2011-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0cf19a2b1b561ca57af950ed096d06b
publicationDate 2016-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-343405-B
titleOfInvention COMPLEXES THAT EMIT ALFA-PARTICULES OBJECTIVE THAT INCLUDE RADIOUCLIDE OF TORIO AND HYDROXYPYRIDINONE CONTAINING BINDING.
abstract The present invention provides a complex directed to a tissue target comprising a portion directed to a tissue target, or an octadentate ligand containing hydroxypyridinone, and the ion of a tone-emitting alpha radionuclide. The invention further provides therapeutic methods employing these complexes, sub-production and use methods, and pharmaceutical kits and compositions comprising these complexes.
priorityDate 2010-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23960
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421335148
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69975
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577459

Total number of triples: 22.